{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/squint-in-children/background-information/causes/","result":{"pageContext":{"chapter":{"id":"924bf7e2-6ba1-5f39-9369-d7f421d0db43","slug":"causes","fullItemName":"Causes","depth":2,"htmlHeader":"<!-- begin field 4c6219ec-fb9b-43c7-b47a-125e2cfeaa38 --><h2>What are the causes of childhood squint?</h2><!-- end field 4c6219ec-fb9b-43c7-b47a-125e2cfeaa38 -->","summary":"","htmlStringContent":"<!-- begin item 50e38973-8fe7-4d17-8dac-856d46bc9674 --><!-- begin field 731c1815-124a-41fd-b3a4-68bfc811a037 --><ul><li><strong>A squint develops because there is lack of coordination that prevents the gaze of both eyes being focused on the same point in space. </strong></li><li><strong>Most squints are idiopathic, or the cause is not clearly defined, </strong>although there are certain <a class=\"topic-reference internal-reference\" href=\"/topics/squint-in-children/background-information/risk-factors/\">risk factors</a> that increase the risk of having a squint. </li><li><strong>Known causes of squint include:</strong><br><ul><li>Refractive errors in one or both eyes, especially hypermetropia (long-sightedness), which are strongly associated with <a class=\"topic-reference internal-reference\" href=\"/topics/squint-in-children/background-information/classification/\">accommodative esotropia</a>. </li><li>Other causes of poor visual acuity or blindness in one or both eyes (a so-called sensory squint), including:<ul><li>Retinoblastoma.</li><li>Cataract.</li><li>Ocular malformations.</li><li>Optic neuropathy.</li><li>Amblyopia (lazy eye), which can also be a <a class=\"topic-reference internal-reference\" href=\"/topics/squint-in-children/background-information/complications/\">complication</a> of a squint.  </li></ul></li><li>Neurodevelopmental conditions and syndromes, such as cerebral palsy and Down syndrome.</li><li>Congenital abnormalities of the extra-ocular muscles or their innervation, such as Brown’s syndrome and Duane's syndrome. </li><li>Diseases that can affect one or more of the extra-ocular muscles or their innervation, such as brain tumours, other brain lesions, head injury, post-viral problems, hydrocephalus, and muscle disorders (for example myasthenia gravis).<ul><li>These are rare in children but need to be considered when a child presents with a squint, particularly where there is a paralytic or incomitant element with reduced eye movements. </li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/squint-in-children/references/\">Yeung, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/squint-in-children/references/\">Tychsen, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/squint-in-children/references/\">Bowling, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/squint-in-children/references/\">Bommireddy, 2020</a>]</p><!-- end field 731c1815-124a-41fd-b3a4-68bfc811a037 --><!-- end item 50e38973-8fe7-4d17-8dac-856d46bc9674 -->","topic":{"id":"d25cf803-28cb-5afd-80ca-d97838356e0c","topicId":"3e67bea0-6e2a-4f62-86eb-6e4c56360437","topicName":"Squint in children","slug":"squint-in-children","lastRevised":"Last revised in January 2021","chapters":[{"id":"b8612b38-b5db-56e8-a543-71e5c697b321","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"780c39cc-055a-53cd-bf74-acd28cc88602","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"afd01e9a-2008-5a2c-9539-10fa84545764","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"6b8c8d6d-89ab-5ea0-ae30-60da95a35e26","slug":"changes","fullItemName":"Changes"},{"id":"3384a548-18ca-5700-81ca-97f085fa4a41","slug":"update","fullItemName":"Update"}]},{"id":"262d6d12-f189-50fe-be83-dc3f7b819c28","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"a04252dd-0eab-51c1-96c3-78aabd585484","slug":"goals","fullItemName":"Goals"},{"id":"ed0abb87-47b9-5dc2-a23a-490395a37a51","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"7ce7f3fa-3b9f-5026-a148-0ea285406c0c","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5250eccf-4fbc-5a72-bab0-669c03e06c58","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0c7cb979-a236-5b84-99c7-2b9fab653503","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d07341e2-26e8-5f76-a64c-4df297389460","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"1b07638c-cefc-5490-8cec-36a5ae1edf50","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"5b4456f3-a699-5733-9492-ab8814081a94","slug":"definition","fullItemName":"Definition"},{"id":"64d3ddca-f1f5-56a1-aa00-e77881d13b5b","slug":"classification","fullItemName":"Classification"},{"id":"a95becad-fc39-5213-a78c-6c3a3fb83ec7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"924bf7e2-6ba1-5f39-9369-d7f421d0db43","slug":"causes","fullItemName":"Causes"},{"id":"7f997f2c-42bc-5372-bc69-68390cfdf9b8","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"679ef8e8-d648-55c5-8ce8-7670d6e927f5","slug":"complications","fullItemName":"Complications"},{"id":"546d7400-5c56-5e32-a702-25a6038faa1b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"683d19f2-df00-5f12-afbb-464c10699f5f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"2559b5e2-6604-5ca4-b15e-d51eb712aee4","slug":"identification","fullItemName":"Identification"},{"id":"ea4d4c60-e84d-5f2f-8759-12f2223894f3","slug":"assessment","fullItemName":"Assessment"}]},{"id":"2072ffc3-2703-5559-ae10-906f961f9c23","fullItemName":"Management","slug":"management","subChapters":[{"id":"3c959293-ed07-5a6e-b857-6ca0fad7a1a3","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"ab53d1f3-0839-5c38-a7c2-7dc1dcd0d403","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a7c5d55f-375b-53c4-8c96-a6800e9816ec","slug":"atropine-eye-drops","fullItemName":"Atropine eye drops"}]},{"id":"bca67f8e-d20f-5aa6-9128-e06b4801b3df","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"195f7f07-a039-5ad4-9619-47ec9f7a17b6","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d19c577a-210d-56ee-a016-2fc7fdb391d3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"96115e23-6d19-55a0-9659-317f379833d5","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3ae1b903-9fac-5f81-99f0-ae27261c65be","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3c6a1cf1-fa3d-589e-a984-9c99b716da6c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a8402308-0a8f-50c4-9974-22016c1078cb","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"bf5d047c-4b2c-5972-993d-649c64937fba","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"1b07638c-cefc-5490-8cec-36a5ae1edf50","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}